Skip to Content

Afluria Approval History

FDA Approved: Yes (First approved September 28, 2007)
Brand name: Afluria
Generic name: influenza virus vaccine
Dosage form: Injection
Company: CSL Biotherapies
Treatment for: Influenza Prophylaxis

Afluria (influenza virus vaccine) is an inactivated influenza virus vaccine, indicated for active immunization against influenza disease.

Development History and FDA Approval Process for Afluria

DateArticle
Sep 14, 2017Approval Seqirus Receives FDA Approval of Afluria Quadrivalent (Influenza Vaccine) for People Five Years of Age and Older in the U.S.
Aug 29, 2016Approval Seqirus Receives FDA Approval for Afluria Quadrivalent (Influenza Vaccine) for People 18 Years of Age and Older
Sep 28, 2007Approval CSL Biotherapies Announces FDA Marketing Approval of Afluria

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide